Intravascular Ultrasound (IVUS) Global Strategic Analysis Report 2024 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intravascular Ultrasound (IVUS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
'Intravascular Ultrasound (IVUS) - Global Strategic Business Report'
Global Intravascular Ultrasound (IVUS) Market to Reach $1.1 Billion by 2030
The global market for Intravascular Ultrasound (IVUS) estimated at US$634.2 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030.
This report provides an overview of Medical Ultrasound, with a specific focus on Intravascular Ultrasound (IVUS) and its applications in the medical field. It begins with a general introduction to medical ultrasound and highlights the advantages of ultrasound as compared to other imaging modalities.
The application areas of ultrasound are explored, and the report delves into Coronary Artery Disease (CAD), including its causes, symptoms, and the common treatment method known as Percutaneous Coronary Intervention (PCI). Intravascular Ultrasound (IVUS) is then introduced, with insights into its high potential in interventional cardiology.
IVUS Catheters, one of the segments analyzed in the report, is projected to record 8.3% CAGR and reach US$659 Million by the end of the analysis period. Growth in the IVUS Consoles segment is estimated at 6.7% CAGR for the next 8-year period.
The report discusses the indications and techniques of Intravascular Ultrasound, providing a comprehensive understanding of its use in medical procedures. The impact of the COVID-19 pandemic on the Intravascular Ultrasound market is also addressed.
Point-of-care Intravascular Ultrasound gains prominence in the context of healthcare delivery, and the report provides information on the Global Key Competitors' Percentage Market Share in 2023, categorizing their Competitive Market Presence as strong, active, niche, or trivial.
The U.S. Market is Estimated at $231.6 Million, While China is Forecast to Grow at 10.1% CAGR
A global market overview highlights the rapid growth of the Intravascular Ultrasound market, driven by factors such as the significance of IVUS catheters and regional dynamics. The dominance of the US and Europe is contrasted with the fastest growth expected in the Asia-Pacific region. Hospitals are identified as the largest contributors to market share.
The Intravascular Ultrasound (IVUS) market in the U.S. is estimated at US$231.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.
What`s New?
Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Attributes:
Report Attribute
Details
No. of Pages
428
Forecast Period
2022 - 2030
Estimated Market Value (USD) in 2022
$634.2 Million
Forecasted Market Value (USD) by 2030
$1100 Million
Compound Annual Growth Rate
7.1%
Regions Covered
Global
MARKET TRENDS & DRIVERS
Rise in Incidence of Cardiovascular Diseases Drives Demand for Intravascular Ultrasound
Global Cardiovascular Ultrasound Procedure Share: 2020E
IVUS Addresses Growing Need for Minimally Invasive Procedures
Global Menace of Coronary Artery Disease (CAD) - A Major Growth Driver
Global Annual Medical Cost of CVD in the United States: 2015-2030
Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Stents Transform CAD Treatment, IVUS Expands Efficacy
Superior Capabilities over Angiography Propels IVUS Adoption
IVUS Inches Forward to Become Standard Choice for Vascular & Arterial Interventions
Angiography vs. IVUS to Measure Vascular Characteristics
IVUS vs. Venography for Venous Interventions
Select List of Studies Comparing Venography to IVUS
IVUS for Arterial Interventions
Advancements in Ultrasound Technology to Benefit Market Growth
Study Links IVUS-Guided PCI with Better Long-Term Patient Outcomes & Low Cardiac Death Risk
Use of IVUS Increases in the Diagnosis of Complex CTO Lesions
Contrast Agents Expand Ultrasound Applications
Commercially Available Contrast Agents for Cardiology Applications
Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Unfurls New Growth Opportunities
Advanced Ultrasound Transducer Designs Simplify IVUS Imaging Applications
Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Rising Middle Class Population Aids Growth
Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020E & 2030P
Rising Healthcare Expenditure: Opportunities in Store
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Risk of CAD in Obesity Offers Prospects for IVUS
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
The Hypertension-Cholesterol Link to Drive Demand
Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
Diabetics at Higher Risk of Heart Diseases
Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
Use of Blockchain in Diagnostic Imaging
FOCUS ON SELECT PLAYERS (Total 15 Featured)
Koninklijke Philips N.V.
For more information about this report visit https://www.researchandmarkets.com/r/f7srvb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.